Search

everythinglearnresearchcommunity

for

Search:↓

A 12-year-old male canine diagnosed with hepatoid cell carcinoma underwent metronomic chemotherapy, resulting in gastroenteric disturbances, generalized alopecia, and loss of visual capacity. Conventional therapy over four months showed no improvement, leading to a suggestion of euthanasia. However, after one month of biorregulatory therapy, the dog exhibited significant health improvements, including recovery from gastroenteropathy, generalized folliculogenesis, and restored vision. The canine achieved full health without the need for ongoing medication and did not experience recurrence of perianal lesions during the biorregulatory therapy period.

A 12-year-old male canine diagnosed with hepatoid cell carcinoma underwent metronomic chemotherapy, resulting in gastroenteric issues, generalized alopecia, and vision loss. Conventional therapy over four months showed no improvement, leading to a suggestion of euthanasia. However, after one month of bioregulatory medicine therapy, the dog exhibited significant health improvements, including recovery from gastroenteropathy, generalized folliculogenesis, and restored vision. The dog achieved full health without needing further medication and did not experience perianal lesion recurrence during bioregulatory therapy. This case highlighted that conventional chemotherapy is not the only therapeutic option, as bioregulatory medicine not only addressed chemotherapy side effects but also enhanced the animal's survival and well-being, offering a favorable prognosis.